Jazz Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $5.771; its P/E ratio is 19.05; Jazz Pharmaceuticals is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $4.19. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 972.14M	$ 946.99M	$ 892.81M	$ 972.12M	$ 940.65M
Gross Profit	$ 1.07B	$ 1.05B	$ 764.17M	$ 804.76M	$ 806.99M
EBIT	$ 99.52M	$ 81.78M	$ 54.10M	$ -265.87M	$ 20.11M
EBITDA	$ 262.08M	$ 241.36M	$ 211.46M	$ -128.48M	$ 168.94M
Net Income Common Stockholders	$ 146.82M	$ 104.44M	$ 69.42M	$ -240.72M	$ -19.65M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.34B	$ 1.28B	$ 1.17B	$ 881.48M	$ 899.36M
Total Assets	$ 11.20B	$ 11.26B	$ 11.04B	$ 10.84B	$ 10.38B
Total Debt	$ 5.78B	$ 5.78B	$ 5.80B	$ 5.81B	$ 5.81B
Net Debt	$ 4.44B	$ 4.50B	$ 4.63B	$ 4.92B	$ 4.92B
Total Liabilities	$ 7.71B	$ 7.73B	$ 7.72B	$ 7.76B	$ 7.64B
Stockholders Equity	$ 3.49B	$ 3.53B	$ 3.34B	$ 3.09B	$ 2.75B
Cash Flow	-
Free Cash Flow	$ 302.90M	$ 291.03M	$ 315.89M	$ 332.59M	$ 422.89M
Operating Cash Flow	$ 307.19M	$ 296.76M	$ 319.71M	$ 341.97M	$ 417.99M
Investing Cash Flow	$ -174.30M	$ -85.74M	$ -4.82M	$ -324.38M	$ 4.60M
Financing Cash Flow	$ -78.49M	$ -96.67M	$ -28.79M	$ 19.60M	$ -289.05M

Currency in USD

Jazz Pharmaceuticals Earnings and Revenue History

Income Statement >

Jazz Pharmaceuticals Debt to Assets

Balance Sheet >

Jazz Pharmaceuticals Cash Flow

Cash Flow >

Jazz Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing